HLA allele frequency and clinical outcome in Italian patients with cutaneous melanoma

HLA‐DR typing by PCR amplification with sequence‐specific primers (PCR‐SSP) in 2 hours: An alternative to serological DR typing in clinical practice including donor‐recipient matching in cadaveric transplantation

1992 • 1,846 citations

Nomenclature for Factors of the HLA System, 2004

2005 • 867 citations

Long-Term Results of a Multi-Institutional Randomized Trial Comparing Prognostic Factors and Surgical Results for Intermediate Thickness Melanomas (1.0 to 4.0 mm)

2000 • 478 citations

Nomenclature for factors of the hla system, 2000

2001 • 143 citations

Multivariate prognostic model for patients with thick cutaneous melanoma: Importance of sentinel lymph node status

2002 • 124 citations

Human leukocyte antigen class I/II alleles and development of human papillomavirus-related cervical neoplasia: results from a case-control study conducted in the United States.

1998 • 120 citations

Common Human Leukocyte Antigen Alleles in Pemphigus Vulgaris and Pemphigus Foliaceus Italian Patients

1999 • 106 citations

Analysis of HLA antigen expression in benign and malignant melanocytic lesions reveals that upregulation of HLA‐G expression correlates with malignant transformation, high inflammatory infiltration and HLA‐A1 genotype

2003 • 92 citations

HLA‐DQB1*0301 association with increased cutaneous melanoma risk

1994 • 83 citations

Analysis of genes within the HLA region affecting susceptibility to ulcerative colitis

1993 • 82 citations

HLA‐DR and ‐DQ alleles in Italian patients with melanoma

1998 • 60 citations

Human papillomavirus type 16 E6 variants and HLA class II alleles among Japanese women with cervical cancer

2003 • 56 citations

HLA‐DQB1*0303 and *0301 alleles influence susceptibility to and prognosis in cutaneous malignant melanoma in the British Caucasian population

1998 • 46 citations

Detailed analysis of the effects of Glu/Lys beta69 human leukocyte antigen-DP polymorphism on peptide-binding specificity

2003 • 39 citations

Malignant melanoma: relationship of the human leukocyte antigen Class II geneDQB1*0301 to disease recurrence in American Joint Committee on Cancer Stage I or II

1996 • 36 citations

Identification of HLA-A*03, A*11 and B*07-restricted melanoma-associated peptides that are immunogenic in vivo by vaccine-induced immune response (VIIR) analysis

2000 • 27 citations

A MAGE‐A1 peptide presented to cytolytic T lymphocytes by both HLA‐B35 and HLA‐A1 molecules

2000 • 25 citations

Presence of the human leukocyte antigen class II geneDRB1*1101 predicts interferon γ levels and disease recurrence in melanoma patients

2002 • 25 citations

Melanoma vaccines: Early progress and future promises

2003 • 21 citations

Nomenclature for factors of the HLA system, 2000

2001 • 20 citations

Molecular Analysis of HLA DRB1 and DQB 1 Polymorphism in Italian Melanoma Patients

1998 • 18 citations

The New Melanoma Staging System

2001 • 14 citations

Regression of melanoma, but not keratoacanthoma, is associated with increased HLA-B22 and decreased HLA-B27 and HLA-DR1

1999 • 8 citations

HLA class I polymorphism and the susceptibility to malignant melanoma.

1996 • 7 citations